Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Resectable Pancreatic Cancer”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Temporarily pausedNCT06211933
What this trial is testing

Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)

Who this might be right for
Non-Resectable Pancreas Carcinoma
Centre Leon Berard 26
Testing effectiveness (Phase 2)WithdrawnNCT03908333
What this trial is testing

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Medical College of Wisconsin
Testing effectiveness (Phase 2)Looking for participantsNCT05116072
What this trial is testing

Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the DuodenumAmpullary Adenocarcinoma
University Hospital, Lille 36
Testing effectiveness (Phase 2)Study completedNCT03410030
What this trial is testing

Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)

Who this might be right for
Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma Resectable+2 more
HonorHealth Research Institute 17
Testing effectiveness (Phase 2)Study completedNCT03727880
What this trial is testing

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Lei Zheng 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07277452
What this trial is testing

Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
The First Affiliated Hospital with Nanjing Medical University 156
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469956
What this trial is testing

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07833241
What this trial is testing

Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPC

Who this might be right for
Borderline Resectable Pancreatic CancerHigh-Risk Resectable Pancreatic Cancer
Shanghai Zhongshan Hospital 56
Testing effectiveness (Phase 2)WithdrawnNCT03697239
What this trial is testing

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Hitendra Patel
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT05083247
What this trial is testing

Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmPancreatic AdenocarcinomaBorderline Resectable Pancreatic Adenocarcinoma
Erasme University Hospital 256
Testing effectiveness (Phase 2)Study completedNCT01560949
What this trial is testing

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 34
Not applicableUnknownNCT05262452
What this trial is testing

Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy EffectUltrasound Therapy
Seoul National University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03146962
What this trial is testing

High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies

Who this might be right for
Colorectal CancerPancreatic CancerLung Cancer
Weill Medical College of Cornell University 61
Large-scale testing (Phase 3)Looking for participantsNCT07436741
What this trial is testing

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Tianjin Medical University Cancer Institute and Hospital 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06210360
What this trial is testing

Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX

Who this might be right for
Pancreatic Cancer
Changhai Hospital 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT03523312
What this trial is testing

Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 47